Omalizumab

Drug Index

Omalizumab, sold under the brand name Xolair, is a medication used to treat asthma, nasal polyps, and urticaria.[5][6] Omalizumab is a recombinant DNA-derived humanized IgG1k monoclonal antibody that specifically binds to free human immunoglobulin E (IgE) in the blood and interstitial fluid and to membrane-bound form of IgE (mIgE) on the surface of mIgE-expressing B lymphocytes.[7] Unlike an ordinary anti-IgE antibody, it does not bind to IgE th...

I have been taking this medication for 5 month and I have experience a lot of hair loss. Spoke with a friend who is taking the medication as well and has experienced tremendous hair loss. She has used Redkin Hair Products, with good success, she has managed to recoup much of her hair. Has anyone else experienced hair loss? ## I too have had hair loss. My hair is very thin now and I haven't touched a razor to my legs in months. ## yeah. I'm 16 and i have. ## Unfortunately, there isn't a lot of side effect information available on this drug, yet. You would probably be surprised to know how many drugs do cause hair loss, though. ## Hi. I am 20 years old and I have been shedding hair like crazy over the past two years..... I am not sure why this is happening. It's not geneti...

76 REPLIES

Omalizumab

Omalizumab, sold under the brand name Xolair, is a medication used to treat asthma, nasal polyps, and urticaria.[5][6] Omalizumab is a recombinant DNA-derived humanized IgG1k monoclonal antibody that specifically binds to free human immunoglobulin E (IgE) in the blood and interstitial fluid and to membrane-bound form of IgE (mIgE) on the surface of mIgE-expressing B lymphocytes.[7] Unlike an ordinary anti-IgE antibody, it does not bind to IgE th...

I am starting Xolair in two days time, any tips on what to expect? ## Xolair contains the active ingredient Omalizumab, it's a humanized antibody used to treat certain types of asthma. Common side effects may include: nausea, drowsiness, headache and injection site irritation. Read more: Does anyone else have anything to add? ## Please do not take it. I have had a lot of hair loss. The back of my head is bald. Just like a person who has had treatments for cancer. I was never told that I would have this much hair. How many of you people who have had this injection have had a lot of hair loss? Not much of my hair has come back in and it has been almost two years.

2 REPLIES

I will be starting Xolair after I am discharged from the hospital (kidney cancer). I would like to know what to expect. Thanks for your comments in advance. Bruce ## Xolair contains the active ingredient Omalizumab and it is not currently approved in the U.S. as a cancer treatment, it is used to treat asthma. Are you certain that is the right name of the medication you are asking about? Preliminary research has actually shown that while this does play a role in the immune systems recognition of cancer cells, it may increase risks of developing cancer. You can read more on it here: ## I have sever asthma and I have been on this drug since 2003 when it first came out. Before this, I was in the ER all the time and now being on this drug I can't say enough it keeps me out of ER and asth...

3 REPLIES

injection ## Please send me some information on side effects of Zolaire injection. ## The correct name of this medication is Xolair, it is an injection used to treat asthma, the active ingredient is Omalizumab.

2 REPLIES

Both the FDA and Health Canada have issued warnings about this pharmaceutical. FDA Proposes to Strengthen Label Warning for Xolair February 21, 2007 - "The Food and Drug Administration (FDA) announced that it has requested Genentech, Inc. add a boxed warning to the product label for omalizumab, marketed as Xolair. The boxed warning emphasizes that Xolair, used to treat patients with asthma related to allergies, may cause anaphylaxis. Anaphylaxis may include trouble breathing, chest tightness, dizziness, fainting, itching and hives, and swelling of the mouth and throat. In addition, FDA has asked Genentech to revise the Xolair label and provide a Medication Guide for patients to strengthen the existing warning for anaphylaxis." Early Communication about an Ongoing Safety Review o...

2 REPLIES

NDC Database

Xolair 202.5 mg/1.4ml Subcutaneous Injection, Solution by Genentech, Inc. ## Package Codes: 50242-040-62, 50242-040-86 ## Active Ingredients: Omalizumab